HASHICORP INC-CL A (HCP)
US4181001037 - Common Stock
Taking everything into account, HCP scores 4 out of 10 in our fundamental rating. HCP was compared to 277 industry peers in the Software industry. While HCP has a great health rating, there are worries on its profitability. HCP is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
HCP had negative earnings in the past year.
In the past year HCP has reported a negative cash flow from operations.
HCP had negative earnings in each of the past 5 years.
HCP had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
HCP has a Return On Assets (-11.27%) which is in line with its industry peers.
With a Return On Equity value of -15.72%, HCP perfoms like the industry average, outperforming 52.17% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.27% | ||
| ROE | -15.72% | ||
| ROIC | N/A |
ROA(3y)-15.33%
ROA(5y)-17.17%
ROE(3y)-20.37%
ROE(5y)-30.92%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Gross Margin value of 81.36%, HCP belongs to the best of the industry, outperforming 85.51% of the companies in the same industry.
HCP's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for HCP so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 81.36% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.31%
GM growth 5Y-0.29%
2. Health
2.1 Basic Checks
HCP does not have a ROIC to compare to the WACC, probably because it is not profitable.
HCP has more shares outstanding than it did 1 year ago.
There is no outstanding debt for HCP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 8.14 indicates that HCP is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 8.14, HCP belongs to the top of the industry, outperforming 81.88% of the companies in the same industry.
HCP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 8.14 |
ROIC/WACCN/A
WACC9.91%
2.3 Liquidity
A Current Ratio of 3.50 indicates that HCP has no problem at all paying its short term obligations.
HCP has a better Current ratio (3.50) than 78.26% of its industry peers.
A Quick Ratio of 3.50 indicates that HCP has no problem at all paying its short term obligations.
With a decent Quick ratio value of 3.50, HCP is doing good in the industry, outperforming 78.26% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.5 | ||
| Quick Ratio | 3.5 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 83.33% over the past year.
The Revenue has grown by 22.53% in the past year. This is a very strong growth!
HCP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 61.00% yearly.
EPS 1Y (TTM)83.33%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q171.43%
Revenue 1Y (TTM)22.53%
Revenue growth 3Y40.14%
Revenue growth 5Y61%
Revenue growth Q2Q14.72%
3.2 Future
Based on estimates for the next years, HCP will show a very strong growth in Earnings Per Share. The EPS will grow by 108.76% on average per year.
Based on estimates for the next years, HCP will show a quite strong growth in Revenue. The Revenue will grow by 16.13% on average per year.
EPS Next Y174.19%
EPS Next 2Y123.3%
EPS Next 3Y108.76%
EPS Next 5YN/A
Revenue Next Year11.98%
Revenue Next 2Y14.42%
Revenue Next 3Y16.13%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
HCP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 494.82, HCP can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HCP indicates a slightly more expensive valuation: HCP is more expensive than 60.51% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of HCP to the average of the S&P500 Index (20.15), we can say HCP is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 494.82 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
HCP's earnings are expected to grow with 108.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y123.3%
EPS Next 3Y108.76%
5. Dividend
5.1 Amount
HCP does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
HASHICORP INC-CL A
NASDAQ:HCP (5/17/2024, 7:03:33 PM)
After market: 33.02 -0.02 (-0.06%)33.04
+0.11 (+0.33%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap6.64B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 494.82 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.27% | ||
| ROE | -15.72% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 81.36% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.34
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 3.5 | ||
| Quick Ratio | 3.5 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)83.33%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y174.19%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)22.53%
Revenue growth 3Y40.14%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y